Who Paid My Doc
Supprelin
Drug Endocrinology
NDC 67979-002-01
General payments
$142,476
Research payments
$2,510
Through program year 2025, $142,476 in general payments and $2,510 in research payments were reported against Supprelin (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,572 | 292 |
| 2024 | General | $28,349 | 250 |
| 2023 | General | $10,263 | 187 |
| 2022 | General | $2,115 | 85 |
| 2021 | General | $6,962 | 117 |
| 2020 | General | $28,701 | 150 |
| 2020 | Research | $1,000 | 1 |
| 2019 | General | $57,514 | 260 |
| 2019 | Research | $1,510 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,341 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.